Found: 102
Select item for more details and to access through your institution.
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 801, doi. 10.1007/s10147-024-02509-z
- By:
- Publication type:
- Article
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 6, p. 1020, doi. 10.1007/s10120-023-01423-z
- By:
- Publication type:
- Article
Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A SingleInstitution Retrospective Study.
- Published in:
- Journal of Gastric Cancer, 2023, v. 23, n. 4, p. 609, doi. 10.5230/jgc.2023.23.e41
- By:
- Publication type:
- Article
Efficacy and Safety of Self-Expandable Metallic Stent Placement for Malignant Esophageal Fistula.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 5859, doi. 10.3390/jcm12185859
- By:
- Publication type:
- Article
Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1191, doi. 10.1007/s10147-023-02370-6
- By:
- Publication type:
- Article
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11067-y
- By:
- Publication type:
- Article
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 4, p. 614, doi. 10.1007/s10120-023-01388-z
- By:
- Publication type:
- Article
KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1273, doi. 10.1007/s00432-022-03966-7
- By:
- Publication type:
- Article
Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1269, doi. 10.1002/cam4.4996
- By:
- Publication type:
- Article
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221138377
- By:
- Publication type:
- Article
Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 121, doi. 10.1007/s10147-022-02263-0
- By:
- Publication type:
- Article
Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8385, doi. 10.1245/s10434-022-12301-w
- By:
- Publication type:
- Article
ASO Visual Abstract: Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Safety and Efficacy of Self-Expandable Metallic Stent Placement Using Low Radial Force Stent for Malignant Dysphagia after Radiotherapy.
- Published in:
- Digestion, 2022, v. 103, n. 4, p. 261, doi. 10.1159/000522007
- By:
- Publication type:
- Article
Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer.
- Published in:
- Health Science Reports, 2022, v. 5, n. 4, p. 1, doi. 10.1002/hsr2.673
- By:
- Publication type:
- Article
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13801-1
- By:
- Publication type:
- Article
Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. e506, doi. 10.1093/oncolo/oyab069
- By:
- Publication type:
- Article
Long‐term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a‐muscularis mucosae and T1b‐submucosa by endoscopic resection followed by appropriate additional treatment.
- Published in:
- Digestive Endoscopy, 2022, v. 34, n. 4, p. 793, doi. 10.1111/den.14154
- By:
- Publication type:
- Article
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 207, doi. 10.1007/s10120-021-01230-4
- By:
- Publication type:
- Article
Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 24, p. 8820, doi. 10.1002/cam4.4384
- By:
- Publication type:
- Article
ASO Visual Abstract: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma—A Comparison of Outcomes Between Esophagectomy and Chemoradiotherapy.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: A Comparison of Outcomes between Esophagectomy and Chemoradiotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 13, p. 8428, doi. 10.1245/s10434-021-10225-5
- By:
- Publication type:
- Article
ASO Author Reflections: Esophagectomy or Chemoradiotherapy, That is the Question: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 13, p. 8436, doi. 10.1245/s10434-021-10261-1
- By:
- Publication type:
- Article
Effect of neutropenia on survival outcomes of patients with metastatic colorectal cancer receiving trifluridine/tipiracil plus bevacizumab.
- Published in:
- Oncology Letters, 2021, v. 22, n. 5, p. N.PAG, doi. 10.3892/ol.2021.13044
- By:
- Publication type:
- Article
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 946, doi. 10.1007/s10120-021-01173-w
- By:
- Publication type:
- Article
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 335, doi. 10.1007/s10147-020-01806-7
- By:
- Publication type:
- Article
Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 2, p. 615, doi. 10.1002/cam4.3638
- By:
- Publication type:
- Article
A multicenter phase II study of TAS-114 in combination with S-1 in patients with pretreated advanced gastric cancer (EPOC1604).
- Published in:
- Gastric Cancer, 2021, v. 24, n. 1, p. 190, doi. 10.1007/s10120-020-01107-y
- By:
- Publication type:
- Article
Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists.
- Published in:
- Surgery Today, 2020, v. 50, n. 10, p. 1197, doi. 10.1007/s00595-020-01995-8
- By:
- Publication type:
- Article
Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 5, p. 1510, doi. 10.1245/s10434-019-08124-x
- By:
- Publication type:
- Article
ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 5, p. 1518, doi. 10.1245/s10434-020-08282-3
- By:
- Publication type:
- Article
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 3, p. 510, doi. 10.1007/s10120-019-01034-7
- By:
- Publication type:
- Article
Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 2, p. 460, doi. 10.1245/s10434-019-07654-8
- By:
- Publication type:
- Article
Efficacy of trastuzumab emtansine in Japanese patients with previously treated HER2‐positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: A subgroup analysis of the GATSBY study.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 1, p. 5, doi. 10.1111/ajco.13243
- By:
- Publication type:
- Article
Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 111, doi. 10.1007/s10637-019-00749-9
- By:
- Publication type:
- Article
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 1, p. 143, doi. 10.1007/s10120-019-00970-8
- By:
- Publication type:
- Article
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 6, p. 1238, doi. 10.1007/s10120-019-00973-5
- By:
- Publication type:
- Article
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 6, p. 1256, doi. 10.1007/s10120-019-00953-9
- By:
- Publication type:
- Article
Non‐V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 9, p. 2488, doi. 10.1002/ijc.32320
- By:
- Publication type:
- Article
Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1197, doi. 10.1007/s10147-019-01477-z
- By:
- Publication type:
- Article
Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 9, p. 2875, doi. 10.1111/cas.14117
- By:
- Publication type:
- Article
Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 8, p. e198243, doi. 10.1001/jamanetworkopen.2019.8243
- By:
- Publication type:
- Article
Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5757, doi. 10.2147/CMAR.S201048
- By:
- Publication type:
- Article
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 3, p. 518, doi. 10.1007/s10120-018-0887-x
- By:
- Publication type:
- Article
Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice